0001104659-21-016806.txt : 20210209
0001104659-21-016806.hdr.sgml : 20210209
20210209180401
ACCESSION NUMBER: 0001104659-21-016806
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210209
FILED AS OF DATE: 20210209
DATE AS OF CHANGE: 20210209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sofinnova Venture Partners X, L.P.
CENTRAL INDEX KEY: 0001680200
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39988
FILM NUMBER: 21608225
BUSINESS ADDRESS:
STREET 1: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-681-8420
MAIL ADDRESS:
STREET 1: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sofinnova Management X, L.L.C.
CENTRAL INDEX KEY: 0001680194
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39988
FILM NUMBER: 21608226
BUSINESS ADDRESS:
STREET 1: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-681-8420
MAIL ADDRESS:
STREET 1: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Katabi Maha
CENTRAL INDEX KEY: 0001720685
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39988
FILM NUMBER: 21608227
MAIL ADDRESS:
STREET 1: SOFINNOVA INVESTMENTS
STREET 2: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POWELL MICHAEL
CENTRAL INDEX KEY: 0001202793
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39988
FILM NUMBER: 21608228
MAIL ADDRESS:
STREET 1: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bolt Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001641281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472804636
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-665-9295
MAIL ADDRESS:
STREET 1: 900 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: Bolt Therapeutics, Inc.
DATE OF NAME CHANGE: 20150504
4
1
tm215893d1_4.xml
OWNERSHIP DOCUMENT
X0306
4
2021-02-09
1
0001641281
Bolt Biotherapeutics, Inc.
BOLT
0001680200
Sofinnova Venture Partners X, L.P.
C/O SOFINNOVA INVESTMENTS, INC.
3000 SAND HILL ROAD, BLDG. 4, SUITE 250
MENLO PARK
CA
94025
0
0
1
0
0001680194
Sofinnova Management X, L.L.C.
C/O SOFINNOVA INVESTMENTS, INC.,
3000 SAND HILL ROAD, BLDG. 4, SUITE 250,
MENLO PARK
CA
94025
0
0
1
0
0001720685
Katabi Maha
C/O SOFINNOVA INVESTMENTS, INC.,
3000 SAND HILL ROAD, BLDG. 4, SUITE 250,
MENLO PARK
CA
94025
0
0
1
0
0001202793
POWELL MICHAEL
C/O SOFINNOVA INVESTMENTS, INC.,
3000 SAND HILL ROAD, BLDG. 4, SUITE 250,
MENLO PARK
CA
94025
0
0
1
0
Common Stock
2021-02-09
4
C
0
1104209
A
1104209
D
Common Stock
2021-02-09
4
C
0
1200228
A
2304437
D
Common Stock
2021-02-09
4
P
0
450000
20
A
2754437
D
Series C-1 Preferred Stock
2021-02-09
4
C
0
1104209
0
D
Common Stock
1104209
0
D
Series C-2 Preferred Stock
2021-02-09
4
C
0
1200228
0
D
Common Stock
1200228
0
D
The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's initial public offering (the "IPO") and had no expiration date.
The shares are held directly by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. James I. Healy, Maha Katabi, and Michael F. Powell are the managing members of SM X and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP X. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein.
The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date.
/s/ Nathalie Auber, as attorney-in-fact for Sofinnova Venture Partners X, L.P.
2021-02-09
/s/ Nathalie Auber, as attorney-in-fact for Sofinnova Management X, L.L.C.
2021-02-09
/s/ Nathalie Auber, as attorney-in-fact for Maha Katabi
2021-02-09
/s/ Nathalie Auber, as attorney-in-fact for Michael F. Powell
2021-02-09